SeaStar Medical (ICU) Appoints Rick Barnett as Chairman of the Board of Directors

November 29, 2022 9:05 AM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

SeaStar Medical Holding Corporation (Nasdaq: ICU), (“SeaStar Medical” or the “Company”), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced the appointment of Rick Barnett as Chairman of the Company’s Board of Directors. Mr. Barnett has served on the SeaStar Medical Board as a Director since January 2021, and currently serves as Chair of the Compensation Committee and a member of the Audit Committee.

Rick Barnett has extensive experience in strategic transactions and financial analysis for healthcare and medical device companies, as well as significant expertise and skills in hospital operations, risk and compliance management. Mr. Barnett joined SeaStar Medical’s Board of Directors after serving as President, Chief Executive Officer and Board Member of Satellite Healthcare, Inc. for seven years. During this time, Mr. Barnett served as the Chairman of the Strategic Planning Committee, as well as a member of the Finance, Quality, Risk/ Compliance, and Governance/Compensation committees for Satellite Healthcare, Inc. Mr. Barnett currently serves on the Board of CutisCare, Inc and is a member of its Strategy and Audit Committee.

“As we continue to evolve and grow as a public company, strengthening and optimizing the expertise of our leadership team is a key area focus. With the appointment of Rick as Chairman, it enables me to be laser focused on executing our business strategy and successfully advancing our development programs. Rick has been a valuable member of our Board since the beginning of last year and is well aligned with our mission and goals. Additionally, his tremendous commercial expertise and over 25 years of hospital and health systems CEO experience, makes him an ideal candidate for the role of Chairman of our Board,” commented Eric Schlorff, Chief Executive Officer of SeaStar Medical.

Mr. Barnett added, “SeaStar Medical has continued to execute on many operational fronts, has advanced the technology and now has entered a new phase as a publicly traded company, with a potential commercial launch of an SCD product candidate in Q2 2023. I am excited to deepen my position with the team and assume the role of Chairman as the Company advances towards a commercial-stage company. I look forward to working more closely with the team to unlock the full potential of SeaStar Medical.”

Mr. Barnett is the Chairman of the board of directors of the National Kidney Foundation – California, Nevada & Pacific Northwest Region. He also serves as a member of the Nominating, Strategic Partnerships, and Membership committees. He also previously served as Chair of the Board of Directors for West Coast Sourcing Solutions, a product procurement company. From 2009 to 2014, Mr. Barnett has served previously as Executive Officer of the West Coast Division and Senior Vice President of VHA, Inc., a purchasing cooperative for community-owned, nonprofit healthcare institutions. He also served as General Partner & Board Member of North State Surgery Centers, LLC, an ambulatory surgical clinic center and Chair of the Board of Directors of the Hospital Council of Northern California - Northern Sierra Section, a non-profit hospital and health systems trade association. Mr. Barnett holds a bachelor’s degree in business administration and management from Pacific Union College and a master’s in business administration from California State University, Fullerton. He also has received the Corporate Director certification from the National Association of Corporate Directors (NACD) in 2021.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Board Changes, Corporate News

Related Entities